Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking AntibodyJon Kenniston, Daniel J. Sexton, Ryan Faucette et al.|Journal of Biological Chemistry|2014Cited by 122
Overcoming adaptive therapy resistance in AML by targeting immune response pathwaysKatelyn Melgar, Daniel T. Starczynowski, Kathleen Hueneman et al.|Science Translational Medicine|2019Cited by 88